February 7, 1996

Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women

HJHoward L. JuddUniversity of Southern California

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

At a dosage of 0.625 mg, the daily administration of CEE enhanced the development of endometrial hyperplasia. Combining CEE with cyclic or continuous MPA or cyclic MP protected the endometrium from hyperplastic changes associated with estrogen-only therapy.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Howard L. Judd (Wed,) studied this question.

synapsesocial.com/papers/69d74e89df21310ab048f4f1 https://doi.org/https://doi.org/10.1001/jama.1996.03530290040035

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Precursors of Corpus Carcinoma Estrogens and Adenomatous Hyperplasia1947 · 225 citations
2Changes in Plasma Lipoprotein and Apolipoprotein Composition in Relation to Oral<i>Versus</i>Percutaneous Administration of Estrogen Alone or in Cyclic Association with Utrogestan in Menopausal Women1991 · 75 citations
3Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.1987 · 88 citations
4A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium.1989 · 73 citations
5THE SIGNIFICANCE OF ATYPICAL ENDOMETRIAL HYPERPLASA1961 · 62 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo